Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy.

Wang, Kaiyuan; Zhang, Xuanbo; Ye, Hao; Wang, Xia; Fan, Zhijin; Lu, Qi; Li, Songhao; Zhao, Jian; Zheng, Shunzhe; He, Zhonggui; Ni, Qianqian; Chen, Xiaoyuan; Sun, Jin

Wang, Kaiyuan; Zhang, Xuanbo; Ye, Hao; Wang, Xia; Fan, Zhijin; Lu, Qi; Li, Songhao; Zhao, Jian; Zheng, Shunzhe; He, Zhonggui; Ni, Qianqian; Chen, Xiaoyuan; Sun, Jin.

Affiliation

Wang K; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, P. R. China.
Zhang X; Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, Singapore, 119074, Singapore.
Ye H; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, P. R. China.
Wang X; Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, Singapore, 119074, Singapore.
Fan Z; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, P. R. China.
Lu Q; Multi-Scale Robotics Lab (MSRL), Institute of Robotics & Intelligent Systems (IRIS), ETH Zurich, Zurich, 8092, Switzerland.
Li S; School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China.
Zhao J; School of Medicine, South China University of Technology, Guangzhou, 510006, P.R. China.
Zheng S; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, P. R. China.
He Z; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, P. R. China.
Ni Q; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, P. R. China.
Chen X; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, P. R. China.
Sun J; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, P. R. China. hezhgui_student@aliyun.com.

Nat Commun ; 14(1): 6748, 2023 10 24.

Article de En | MEDLINE | ID: mdl-37875481

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins anticancéreux / Tumeurs Limites: Humans Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2023 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google